News

Wednesday, September 10, 2014, Ottawa — Dr. Brian O’Rourke, President and CEO of CADTH, today announced the appointment of three new core members to the Health Technology Expert Review Panel: Jenny Basran, MD, FRCPC — Internist Geriatrician and Associate Professor in the Department of Medicine at the University of Saskatchewan Leslie Anne Ca...

September 3, 2014, Ottawa — Dr. Brian O’Rourke, President and CEO of CADTH, today announced changes to the leadership of the Canadian Drug Expert Committee. Dr. Lindsay Nicolle has been appointed the new Chair of the committee and Dr. James Silvius has been appointed Vice-Chair. Their appointments are for two and three-year terms respectively a...

June 24, 2014 - The creation of an Advisory Panel on Healthcare Innovation, announced earlier today by federal Health Minister Rona Ambrose, will help ensure all Canadians benefit from health innovation, said Dr. Brian O’Rourke, President and CEO of CADTH, the pan-Canadian health technology assessment agency. “There are two positive aspects to ...

The Canadian Agency for Drugs and Technologies in Health (CADTH) has implemented a pilot process for receiving patient input submissions for therapeutic reviews from patient groups. Patient groups are invited to provide experiences and perspectives about living with the condition for which the drugs included in the therapeutic review are indicat...